04/13/2022
Revolution MD Executes Letter of Intent with Flagship Capital for Multi-Million Dollar Investment
Learn more about becoming a shareholder at www.startengine.com/revolution-md
April 13, 2022 -- Revolution MD is a biotech innovator focused on controlling how opioids are safely dispensed. Flagship Capital Legacy Fund is a social impact/ESG fund.